Imidate

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameImidate
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTissue factor inhibitorsRibonucleotide reductase inhibitorsFree radicals scavengers
TargetsTissue factorFree radicalsRibonucleotide reductase
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMolecules for Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecules for Health Inc
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A